NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!

Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.

Start Free »

Smith & Nephew plc SNN | NYSE

$30.88 $1.65 | 5.64%

TREND SIGNAL: Signal available — unlock to view

|2026-10-20

Add to favoritesFavorite

Company Overview:

Market Cap: $12.92B

Trailing PE: 11.9x

FWD PE: —

Payout Ratio (TTM): 58.6%

52-Week Range: $26.12 - $37.09

10 Year SNN Performance Metrics:

Total Return (with DRIP): 28.6% (2.55% CAGR)

Total Return (no DRIP): 26.8% (2.40% CAGR)

Share Price: 2.5% (0.25% CAGR)

Yield on Cost (with DRIP): 2.60%

Total Invested: $10,000

Total Value (with DRIP): $12,864

Total Return $ (with DRIP): $2,864

Dividend Increase: 87.8% (6.88% CAGR)

Dividend Yield (FWD): 2.02% ($0.62)

SNN 10-yr Total Return ($10K invested)

1M 3M 6M YTD 1Y 3Y 5Y 10Y

SNN Share Price

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

SNN Price CAGR:1Y: -16.92%2Y: 2.42%5Y: -2.84%10Y: 0.16%

SNN Dividend Charts

SNN - Dividends

SNN Dividend CAGR:1Y: 4.00%2Y: 4.08%5Y: 1.61%10Y: 2.41%

SNN - Dividend Payout Ratio

SNN Dividend Payout Ratio CAGR:1Y: -28.32%2Y: -30.10%5Y: 22.88%10Y: 0.00%

SNN - Dividend to Free Cash Flow Ratio

SNN Dividend to FCF Ratio CAGR:1Y: -74.24%2Y: 21.27%5Y: 35.02%10Y: 0.00%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

SNN Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

SNN - Revenue

SNN Revenue CAGR:1Y: 9.55%2Y: 48.34%5Y: 4.98%10Y: 12.44%

SNN - Earnings Per Share (EPS)

SNN EPS CAGR:1Y: 180.00%2Y: 266.55%5Y: 6.54%10Y: 8.49%

SNN - Net Income

🔓 See the full chart40% off right now · 7-day free trial

SNN Net Income CAGR:1Y: 41.59%2Y: 158.06%5Y: -7.32%10Y: 8.26%

SNN - EBITDA

🔓 See the full chart40% off right now · 7-day free trial

SNN EBITDA CAGR:1Y: 43.85%2Y: 65.68%5Y: 2.88%10Y: 10.73%

SNN - Free Cash Flow

🔓 See the full chart40% off right now · 7-day free trial

SNN Free Cash Flow CAGR:1Y: 293.94%2Y: 48.75%5Y: -15.65%10Y: 8.13%

SNN - Free Cash Flow / Share

🔓 See the full chart40% off right now · 7-day free trial

SNN Free Cash Flow / Share CAGR:1Y: 301.82%2Y: 50.37%5Y: -15.32%10Y: 1.24%

SNN - Operating Income

🔓 See the full chart40% off right now · 7-day free trial

SNN Operating Income CAGR:1Y: 36.59%2Y: 48.37%5Y: -1.00%10Y: 60.30%

SNN - Gross Profit

🔓 See the full chart40% off right now · 7-day free trial

SNN Gross Profit CAGR:1Y: 11.25%2Y: 48.41%5Y: 0.00%10Y: 0.00%

SNN - Shares Outstanding

🔓 See the full chart40% off right now · 7-day free trial

SNN Shares Outstanding CAGR:1Y: -50.73%2Y: -29.78%5Y: -13.22%10Y: -0.34%

SNN - Share Buybacks

🔓 See the full chart40% off right now · 7-day free trial

SNN Share Buybacks CAGR:1Y: 0.00%2Y: 1,423.15%5Y: 46.83%10Y: 0.00%

SNN - Stock-Based Comp

🔓 See the full chart40% off right now · 7-day free trial

SNN Stock-Based Comp CAGR:1Y: 70.00%2Y: 84.39%5Y: 16.27%10Y: 18.94%

SNN - Expenses

🔓 See the full chart40% off right now · 7-day free trial

SNN Expenses CAGR:1Y: 10.47%2Y: 20.89%5Y: 7.89%10Y: 12.41%

SNN - Revenue vs Net Income

🔓 See the full chart40% off right now · 7-day free trial

SNN - EPS vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

SNN - EPS vs PE Ratio

🔓 See the full chart40% off right now · 7-day free trial

SNN - FCF vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

SNN - FCF vs Stock Based Comp

🔓 See the full chart40% off right now · 7-day free trial

SNN - Cash & Debt

🔓 See the full chart40% off right now · 7-day free trial

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

SNN - REVENUE: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

SNN Actual Revenue CAGR:1Y: 9.55%2Y: 48.34%5Y: 4.98%10Y: 12.44%

SNN - EPS: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

SNN Actual EPS CAGR:1Y: 180.00%2Y: 266.55%5Y: 6.54%10Y: 8.49%

SNN - NET INCOME: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

SNN Actual Net Income CAGR:1Y: 41.59%2Y: 158.06%5Y: -7.32%10Y: 8.26%

SNN - EBITDA: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

SNN Actual EBITDA CAGR:1Y: 43.85%2Y: 65.68%5Y: 2.88%10Y: 10.73%

Ratios, Profit Margins & Return on Capital:

SNN - Net Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

SNN Net Profit Margin CAGR:1Y: 29.19%2Y: 74.01%5Y: -11.72%10Y: -3.72%

SNN - Gross Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

SNN Gross Profit Margin CAGR:1Y: 1.55%2Y: 0.06%5Y: -0.70%10Y: -0.49%

SNN - Price to Earnings

🔓 See the full chart40% off right now · 7-day free trial

SNN Price to Earnings CAGR:1Y: -59.86%2Y: -59.10%5Y: -10.21%10Y: -4.07%

SNN - Price To Sales Ratio

🔓 See the full chart40% off right now · 7-day free trial

SNN Price To Sales Ratio CAGR:1Y: -47.21%2Y: -28.23%5Y: -20.45%10Y: -7.48%

SNN - Return on Capital Employed

🔓 See the full chart40% off right now · 7-day free trial

SNN Return on Capital Employed CAGR:1Y: 40.92%2Y: 41.41%5Y: -6.10%10Y: 47.91%

SNN - Return on Invested Capital

🔓 See the full chart40% off right now · 7-day free trial

SNN Return on Invested Capital CAGR:1Y: 23.60%2Y: 39.36%5Y: -10.55%10Y: 42.66%

SNN Dividends Info:

Annual Dividend: $0.624

Forward Yield: 2.02%

Ex-Dividend Date: 2026-10-02

Lifetime Dividends / Share: $10.84

SNN Dividend History: Dates, Payments & Yield list

Below is a schedule of all SNN dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date	Payment Date	Amount	Yield	Forward Yield	Price on Ex-Date
10/02/2026	11/06/2026	$0.312	2.36%	2.32%	$26.92
03/27/2026	05/27/2026	$0.482	3.05%	3.19%	$30.21
10/03/2025	11/07/2025	$0.300	1.65%	1.81%	$33.23
03/28/2025	05/28/2025	$0.462	3.29%	3.23%	$28.61
10/04/2024	11/08/2024	$0.288	1.92%	2.37%	$24.29
04/01/2024	05/22/2024	$0.462	3.77%	3.61%	$25.63
10/05/2023	11/01/2023	$0.288	2.45%	2.58%	$22.32
03/30/2023	05/17/2023	$0.462	3.37%	2.84%	$32.50
09/29/2022	10/26/2022	$0.288	2.52%	2.41%	$23.88
03/31/2022	05/11/2022	$0.462	2.9%	3.11%	$29.72
09/30/2021	10/27/2021	$0.288	1.68%	1.62%	$35.51
04/05/2021	05/12/2021	$0.462	2.43%	2.21%	$41.84
10/01/2020	10/28/2020	$0.288	1.45%	1.62%	$35.65
04/02/2020	05/06/2020	$0.462	2.71%	2.31%	$40.04
10/03/2019	10/30/2019	$0.288	1.25%	1.3%	$44.42
04/04/2019	05/08/2019	$0.440	2.22%	2.13%	$41.40
10/04/2018	10/31/2018	$0.280	1.55%	1.7%	$32.88
04/05/2018	05/09/2018	$0.454	2.42%	2.54%	$35.73
10/05/2017	11/01/2017	$0.246	1.35%	1.33%	$36.91
03/29/2017	05/10/2017	$0.370	2.39%	2.18%	$34.01
10/05/2016	10/25/2016	$0.246	1.52%	1.65%	$29.85
04/20/2016	05/11/2016	$0.380	2.25%	2.25%	$33.85
10/07/2015	10/27/2015	$0.236	1.37%	1.35%	$34.88
04/15/2015	05/06/2015	$0.372	2.16%	2.18%	$34.09
10/22/2014	11/11/2014	$0.220	1.4%	1.3%	$33.91
04/17/2014	05/07/2014	$0.340	2.32%	2.18%	$31.19
10/09/2013	10/29/2013	$0.208	1.72%	1.61%	$25.80
04/17/2013	05/08/2013	$0.324	2.92%	2.74%	$23.67
10/10/2012	10/30/2012	$0.198	1.89%	1.87%	$21.19
04/18/2012	05/09/2012	$0.216	2.19%	2.19%	$19.72
10/12/2011	11/01/2011	$0.132	1.45%	1.49%	$17.74
04/29/2011	05/19/2011	$0.196	1.77%	1.74%	$22.63
10/13/2010	11/02/2010	$0.120	1.36%	1.35%	$17.72
10/14/2009	11/03/2009	$0.109	1.28%	1.23%	$17.79
04/15/2009	05/08/2009	$0.162	2.3%	2.3%	$14.14

Projected Future Returns & Dividends for SNN

Based on past 10-year performance, here are SNN growth metrics:

Share price CAGR of +0.16%
Dividend CAGR of +2.41%

Using SNN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	SNN (DRIP)	SNN - No DRIP
Current Price	$30.88	$30.88
Start Shares	323.83	323.83
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	404.54	323.83
Dividends Payment	$0.40	$0.40
Annual Dividends	$320	$256
Yield on cost	3.20%	2.56%
Share Price	$31.37	$31.37
Total Dividends	$2,511	$2,254
Final Value	$12,689	$12,412

Estimated Future Value + Dividends - SNN

NOTE: Above numbers are our estimate based on SNN's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Company Info

Smith & Nephew plc (SNN) had its IPO on 1999-11-16, and is traded on NYSE stock exchange.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

SNN website: https://www.smith-nephew.com

Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

DCF Model — SNN

Value from:

EPS (TTM)icompany profit per share over the last 12 months

EPS Growth %ihow fast profit per share grows each of the next 5 years — prefilled with what analysts expect

EPS growth after year 5 (forever)ithe slower pace once the fast 5 years are over — only drives years 6-10 of the price path below

Exit multiple (PE in 5 yrs)iwhat buyers pay per $1 of profit in 2031 — prefilled with today’s forward PE

Desired return %/yrithe yearly return you want from buying today — the S&P has done ~14%/yr, ask for more from a single stock

FCF growth %/yr (next 5 yrs)ihow fast free cash flow grows while the company is still expanding fast

Years of fast FCF growthihow many years the fast growth lasts before the business settles down

FCF growth after year 5 (forever)ithe slow, steady pace once the company is mature — usually 2-3%, near inflation. Must stay below your target return

Risk-free rate %iwhat a 10-yr US treasury pays with zero risk — the floor any risky stock must beat

Your target return %/yrithe yearly return you want for taking this risk — rule of thumb: risk-free rate + extra for risk

FCF base ($M, TTM)ilast 12 months of free cash flow, added up from reported quarters

Include dividends in returnidividends hand you part of the return in cash, so the share price needs to climb less

Pay up to today

—

vs current price $30.88

—

Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today

—

grows for the next years

Then mature

—

every future dollar counted back to today

Pile of today-dollars

—

÷ shares

Implied price path

Year	FCF	Implied price

Sensitivity — fair value: growth ↓ × target return →